| Literature DB >> 19946272 |
Frederick J Sheedy1, Eva Palsson-McDermott, Elizabeth J Hennessy, Cara Martin, John J O'Leary, Qingguo Ruan, Derek S Johnson, Youhai Chen, Luke A J O'Neill.
Abstract
The tumor suppressor PDCD4 is a proinflammatory protein that promotes activation of the transcription factor NF-kappaB and suppresses interleukin 10 (IL-10). Here we found that mice deficient in PDCD4 were protected from lipopolysaccharide (LPS)-induced death. The induction of NF-kappaB and IL-6 by LPS required PDCD4, whereas LPS enhanced IL-10 induction in cells lacking PDCD4. Treatment of human peripheral blood mononuclear cells with LPS resulted in lower PDCD4 expression, which was due to induction of the microRNA miR-21 via the adaptor MyD88 and NF-kappaB. Transfection of cells with a miR-21 precursor blocked NF-kappaB activity and promoted IL-10 production in response to LPS, whereas transfection with antisense oligonucleotides to miR-21 or targeted protection of the miR-21 site in Pdcd4 mRNA had the opposite effect. Thus, miR-21 regulates PDCD4 expression after LPS stimulation.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19946272 DOI: 10.1038/ni.1828
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606